Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Virtual Reality Headsets and Seizure Risk in People With Epilepsy

Tests whether wearing virtual reality headsets raises seizure risk in people with epilepsy.

Plain-language title generated from the registry record
Registry title: Epileptiform Potential of Fully Immersive Virtual Reality

Key facts

Where
Lebanon, United StatesSee the site

Where in United States

  • Dartmouth Hitchcock Medical CenterLebanon, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Dartmouth-Hitchcock Medical Center
Trial code
NCT07451093
Record updated
27 August 2026
Original description
The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are:Read full original descriptionShow less

Epileptiform Potential of Fully Immersive Virtual Reality

The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are:

- does use of virtual reality headsets with hand controllers result in a higher risk of seizure compared to use of virtual reality headsets without hand controllers Participants will be asked to wear a virtual reality headset during continuous video EEG recording and EEG with be evaluated during three phases: with display turned off, with display turned on without hand controllers, and with display turned on with hand controllers.

Inclusion: subjects with known or suspected diagnosis of epilepsy with interictal epileptiform discharges seen during current or prior EEG recording; Age greater than or equal to 13 years.

Exclusion: Moderate-severe cognitive impairment; Age less than 13 years (infants, children); Pregnancy; Incarceration.

ClinicalTrials.gov NCT07451093